nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Clonidine—glaucoma	0.118	0.228	CbGbCtD
Argatroban—CYP3A4—Pilocarpine—glaucoma	0.0939	0.182	CbGbCtD
Argatroban—CYP3A4—Brinzolamide—glaucoma	0.0737	0.143	CbGbCtD
Argatroban—CYP3A4—Dorzolamide—glaucoma	0.0712	0.138	CbGbCtD
Argatroban—CYP3A4—Methazolamide—glaucoma	0.0634	0.123	CbGbCtD
Argatroban—CYP3A4—Acetazolamide—glaucoma	0.0507	0.0982	CbGbCtD
Argatroban—CYP3A4—Clonidine—glaucoma	0.0459	0.0888	CbGbCtD
Argatroban—F2—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—DHPS—glaucoma	0.00749	0.119	CbGpPWpGaD
Argatroban—F2—Complement and Coagulation Cascades—C1QB—glaucoma	0.00192	0.0307	CbGpPWpGaD
Argatroban—F2—Regulation of IGF Activity by IGFBP—MMP1—glaucoma	0.00164	0.0262	CbGpPWpGaD
Argatroban—F2—Regulation of IGF Activity by IGFBP—MMP2—glaucoma	0.00127	0.0203	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TXN—glaucoma	0.00124	0.0198	CbGpPWpGaD
Argatroban—F2—Post-translational protein modification—DHPS—glaucoma	0.00122	0.0195	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—ABCA1—glaucoma	0.00119	0.019	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—OPN4—glaucoma	0.00114	0.0181	CbGpPWpGaD
Argatroban—CYP3A5—Tamoxifen metabolism—CYP1B1—glaucoma	0.00111	0.0178	CbGpPWpGaD
Argatroban—F2—Syndecan-4-mediated signaling events—FN1—glaucoma	0.00107	0.0171	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—SOD1—glaucoma	0.00106	0.0169	CbGpPWpGaD
Argatroban—Body temperature increased—Methazolamide—glaucoma	0.00106	0.00251	CcSEcCtD
Argatroban—Dizziness—Metipranolol—glaucoma	0.00105	0.0025	CcSEcCtD
Argatroban—Chest pain—Bimatoprost—glaucoma	0.00104	0.00248	CcSEcCtD
Argatroban—Hypersensitivity—Levobunolol—glaucoma	0.00103	0.00244	CcSEcCtD
Argatroban—Infection—Apraclonidine—glaucoma	0.00103	0.00244	CcSEcCtD
Argatroban—F2—G alpha (q) signalling events—PTGFR—glaucoma	0.00102	0.0163	CbGpPWpGaD
Argatroban—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00102	0.0163	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00102	0.0162	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MYLK—glaucoma	0.00101	0.0162	CbGpPWpGaD
Argatroban—Back pain—Dorzolamide—glaucoma	0.001	0.00238	CcSEcCtD
Argatroban—Rash—Metipranolol—glaucoma	0.001	0.00238	CcSEcCtD
Argatroban—Dermatitis—Metipranolol—glaucoma	0.001	0.00238	CcSEcCtD
Argatroban—Back pain—Travoprost—glaucoma	0.000999	0.00237	CcSEcCtD
Argatroban—Headache—Metipranolol—glaucoma	0.000997	0.00237	CcSEcCtD
Argatroban—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000997	0.0159	CbGpPWpGaD
Argatroban—Infection—Bimatoprost—glaucoma	0.000995	0.00236	CcSEcCtD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000989	0.0158	CbGpPWpGaD
Argatroban—Back pain—Brinzolamide—glaucoma	0.000987	0.00234	CcSEcCtD
Argatroban—Dizziness—Carteolol—glaucoma	0.000975	0.00232	CcSEcCtD
Argatroban—Urinary tract infection—Clonidine—glaucoma	0.000974	0.00231	CcSEcCtD
Argatroban—Diarrhoea—Carbachol—glaucoma	0.000968	0.0023	CcSEcCtD
Argatroban—F2—Folate Metabolism—ABCA1—glaucoma	0.000967	0.0154	CbGpPWpGaD
Argatroban—Dizziness—Diclofenamide—glaucoma	0.000959	0.00228	CcSEcCtD
Argatroban—Diarrhoea—Levobunolol—glaucoma	0.000953	0.00226	CcSEcCtD
Argatroban—F2—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.000953	0.0152	CbGpPWpGaD
Argatroban—Angina pectoris—Betaxolol—glaucoma	0.000953	0.00226	CcSEcCtD
Argatroban—Back pain—Pilocarpine—glaucoma	0.000948	0.00225	CcSEcCtD
Argatroban—Cough—Brimonidine—glaucoma	0.000948	0.00225	CcSEcCtD
Argatroban—Cardiac failure—Timolol—glaucoma	0.000948	0.00225	CcSEcCtD
Argatroban—Nausea—Metipranolol—glaucoma	0.000945	0.00225	CcSEcCtD
Argatroban—Cerebrovascular accident—Timolol—glaucoma	0.000944	0.00224	CcSEcCtD
Argatroban—Dizziness—Carbachol—glaucoma	0.000936	0.00222	CcSEcCtD
Argatroban—Confusional state—Acetazolamide—glaucoma	0.000932	0.00221	CcSEcCtD
Argatroban—Chest pain—Brimonidine—glaucoma	0.000925	0.0022	CcSEcCtD
Argatroban—Headache—Carteolol—glaucoma	0.000924	0.00219	CcSEcCtD
Argatroban—Vomiting—Diclofenamide—glaucoma	0.000922	0.00219	CcSEcCtD
Argatroban—Dizziness—Levobunolol—glaucoma	0.000921	0.00219	CcSEcCtD
Argatroban—Dyspnoea—Apraclonidine—glaucoma	0.000921	0.00219	CcSEcCtD
Argatroban—Bradycardia—Clonidine—glaucoma	0.000916	0.00217	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000915	0.0146	CbGpPWpGaD
Argatroban—Rash—Diclofenamide—glaucoma	0.000914	0.00217	CcSEcCtD
Argatroban—Diarrhoea—Methazolamide—glaucoma	0.000913	0.00217	CcSEcCtD
Argatroban—Headache—Diclofenamide—glaucoma	0.000908	0.00216	CcSEcCtD
Argatroban—Cough—Dorzolamide—glaucoma	0.000905	0.00215	CcSEcCtD
Argatroban—Cough—Travoprost—glaucoma	0.000902	0.00214	CcSEcCtD
Argatroban—Vomiting—Carbachol—glaucoma	0.0009	0.00214	CcSEcCtD
Argatroban—Dyspnoea—Bimatoprost—glaucoma	0.000893	0.00212	CcSEcCtD
Argatroban—Rash—Carbachol—glaucoma	0.000892	0.00212	CcSEcCtD
Argatroban—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000892	0.00212	CcSEcCtD
Argatroban—Dermatitis—Carbachol—glaucoma	0.000891	0.00212	CcSEcCtD
Argatroban—Cough—Brinzolamide—glaucoma	0.00089	0.00211	CcSEcCtD
Argatroban—Headache—Carbachol—glaucoma	0.000886	0.00211	CcSEcCtD
Argatroban—Chest pain—Dorzolamide—glaucoma	0.000883	0.0021	CcSEcCtD
Argatroban—Pain—Apraclonidine—glaucoma	0.000883	0.0021	CcSEcCtD
Argatroban—Constipation—Apraclonidine—glaucoma	0.000883	0.0021	CcSEcCtD
Argatroban—Dyspepsia—Bimatoprost—glaucoma	0.000882	0.00209	CcSEcCtD
Argatroban—Infection—Brimonidine—glaucoma	0.000881	0.00209	CcSEcCtD
Argatroban—Chest pain—Travoprost—glaucoma	0.00088	0.00209	CcSEcCtD
Argatroban—Cardiac arrest—Timolol—glaucoma	0.000879	0.00209	CcSEcCtD
Argatroban—Pneumonia—Betaxolol—glaucoma	0.000877	0.00208	CcSEcCtD
Argatroban—Nausea—Carteolol—glaucoma	0.000876	0.00208	CcSEcCtD
Argatroban—Headache—Levobunolol—glaucoma	0.000873	0.00207	CcSEcCtD
Argatroban—Chest pain—Brinzolamide—glaucoma	0.000868	0.00206	CcSEcCtD
Argatroban—Tachycardia—Brimonidine—glaucoma	0.000865	0.00206	CcSEcCtD
Argatroban—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000865	0.00205	CcSEcCtD
Argatroban—F2—Folate Metabolism—SOD1—glaucoma	0.000862	0.0138	CbGpPWpGaD
Argatroban—Nausea—Diclofenamide—glaucoma	0.000861	0.00205	CcSEcCtD
Argatroban—Acute coronary syndrome—Betaxolol—glaucoma	0.00086	0.00204	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—MMP9—glaucoma	0.000859	0.0137	CbGpPWpGaD
Argatroban—Pain—Bimatoprost—glaucoma	0.000856	0.00203	CcSEcCtD
Argatroban—Cough—Pilocarpine—glaucoma	0.000856	0.00203	CcSEcCtD
Argatroban—Myocardial infarction—Betaxolol—glaucoma	0.000855	0.00203	CcSEcCtD
Argatroban—Dizziness—Latanoprost—glaucoma	0.000854	0.00203	CcSEcCtD
Argatroban—Confusional state—Dorzolamide—glaucoma	0.000854	0.00203	CcSEcCtD
Argatroban—Feeling abnormal—Apraclonidine—glaucoma	0.000851	0.00202	CcSEcCtD
Argatroban—Vomiting—Methazolamide—glaucoma	0.000849	0.00202	CcSEcCtD
Argatroban—Gastrointestinal pain—Apraclonidine—glaucoma	0.000845	0.00201	CcSEcCtD
Argatroban—Rash—Methazolamide—glaucoma	0.000842	0.002	CcSEcCtD
Argatroban—Dermatitis—Methazolamide—glaucoma	0.000841	0.002	CcSEcCtD
Argatroban—Nausea—Carbachol—glaucoma	0.00084	0.002	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—MTHFR—glaucoma	0.00084	0.0134	CbGpPWpGaD
Argatroban—Infection—Travoprost—glaucoma	0.000838	0.00199	CcSEcCtD
Argatroban—Headache—Methazolamide—glaucoma	0.000836	0.00199	CcSEcCtD
Argatroban—Chest pain—Pilocarpine—glaucoma	0.000835	0.00198	CcSEcCtD
Argatroban—Hypotension—Brimonidine—glaucoma	0.000829	0.00197	CcSEcCtD
Argatroban—Nausea—Levobunolol—glaucoma	0.000828	0.00197	CcSEcCtD
Argatroban—Infection—Brinzolamide—glaucoma	0.000827	0.00196	CcSEcCtD
Argatroban—Tachycardia—Travoprost—glaucoma	0.000823	0.00195	CcSEcCtD
Argatroban—Abdominal pain—Apraclonidine—glaucoma	0.000817	0.00194	CcSEcCtD
Argatroban—Angiopathy—Clonidine—glaucoma	0.000816	0.00194	CcSEcCtD
Argatroban—Rash—Latanoprost—glaucoma	0.000815	0.00193	CcSEcCtD
Argatroban—Dermatitis—Latanoprost—glaucoma	0.000814	0.00193	CcSEcCtD
Argatroban—Dyspepsia—Acetazolamide—glaucoma	0.000813	0.00193	CcSEcCtD
Argatroban—Tachycardia—Brinzolamide—glaucoma	0.000813	0.00193	CcSEcCtD
Argatroban—Headache—Latanoprost—glaucoma	0.000809	0.00192	CcSEcCtD
Argatroban—Confusional state—Pilocarpine—glaucoma	0.000807	0.00192	CcSEcCtD
Argatroban—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000798	0.00189	CcSEcCtD
Argatroban—Bradycardia—Betaxolol—glaucoma	0.000797	0.00189	CcSEcCtD
Argatroban—Infection—Pilocarpine—glaucoma	0.000795	0.00189	CcSEcCtD
Argatroban—Nausea—Methazolamide—glaucoma	0.000793	0.00188	CcSEcCtD
Argatroban—Hypotension—Dorzolamide—glaucoma	0.000791	0.00188	CcSEcCtD
Argatroban—Dyspnoea—Brimonidine—glaucoma	0.000791	0.00188	CcSEcCtD
Argatroban—Hypotension—Travoprost—glaucoma	0.000788	0.00187	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—APOE—glaucoma	0.000782	0.0125	CbGpPWpGaD
Argatroban—Tachycardia—Pilocarpine—glaucoma	0.000781	0.00186	CcSEcCtD
Argatroban—Dyspepsia—Brimonidine—glaucoma	0.000781	0.00185	CcSEcCtD
Argatroban—Angina pectoris—Timolol—glaucoma	0.000779	0.00185	CcSEcCtD
Argatroban—Hypotension—Brinzolamide—glaucoma	0.000778	0.00185	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000768	0.0123	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Brimonidine—glaucoma	0.000766	0.00182	CcSEcCtD
Argatroban—F2—Post-translational protein modification—CTSA—glaucoma	0.000765	0.0122	CbGpPWpGaD
Argatroban—Feeling abnormal—Acetazolamide—glaucoma	0.000761	0.00181	CcSEcCtD
Argatroban—Hypersensitivity—Apraclonidine—glaucoma	0.000761	0.00181	CcSEcCtD
Argatroban—Pain—Brimonidine—glaucoma	0.000758	0.0018	CcSEcCtD
Argatroban—Dyspnoea—Dorzolamide—glaucoma	0.000755	0.00179	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000752	0.012	CbGpPWpGaD
Argatroban—Dyspnoea—Travoprost—glaucoma	0.000752	0.00179	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.000749	0.012	CbGpPWpGaD
Argatroban—Hypotension—Pilocarpine—glaucoma	0.000748	0.00178	CcSEcCtD
Argatroban—F2—Complement and Coagulation Cascades—C3—glaucoma	0.000747	0.0119	CbGpPWpGaD
Argatroban—Dyspepsia—Dorzolamide—glaucoma	0.000745	0.00177	CcSEcCtD
Argatroban—Dyspnoea—Brinzolamide—glaucoma	0.000742	0.00176	CcSEcCtD
Argatroban—Dyspepsia—Travoprost—glaucoma	0.000742	0.00176	CcSEcCtD
Argatroban—Dyspepsia—Brinzolamide—glaucoma	0.000733	0.00174	CcSEcCtD
Argatroban—Body temperature increased—Acetazolamide—glaucoma	0.00073	0.00173	CcSEcCtD
Argatroban—Gastrointestinal disorder—Travoprost—glaucoma	0.000728	0.00173	CcSEcCtD
Argatroban—Pain—Dorzolamide—glaucoma	0.000724	0.00172	CcSEcCtD
Argatroban—Pain—Travoprost—glaucoma	0.000721	0.00171	CcSEcCtD
Argatroban—Constipation—Travoprost—glaucoma	0.000721	0.00171	CcSEcCtD
Argatroban—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000719	0.00171	CcSEcCtD
Argatroban—Dyspnoea—Pilocarpine—glaucoma	0.000713	0.00169	CcSEcCtD
Argatroban—Pain—Brinzolamide—glaucoma	0.000712	0.00169	CcSEcCtD
Argatroban—Angiopathy—Betaxolol—glaucoma	0.00071	0.00169	CcSEcCtD
Argatroban—Diarrhoea—Apraclonidine—glaucoma	0.000707	0.00168	CcSEcCtD
Argatroban—Dyspepsia—Pilocarpine—glaucoma	0.000704	0.00167	CcSEcCtD
Argatroban—Feeling abnormal—Dorzolamide—glaucoma	0.000698	0.00166	CcSEcCtD
Argatroban—Feeling abnormal—Travoprost—glaucoma	0.000695	0.00165	CcSEcCtD
Argatroban—Gastrointestinal pain—Dorzolamide—glaucoma	0.000692	0.00164	CcSEcCtD
Argatroban—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000691	0.00164	CcSEcCtD
Argatroban—Gastrointestinal pain—Travoprost—glaucoma	0.00069	0.00164	CcSEcCtD
Argatroban—Feeling abnormal—Brinzolamide—glaucoma	0.000686	0.00163	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—SOD1—glaucoma	0.000685	0.0109	CbGpPWpGaD
Argatroban—Constipation—Pilocarpine—glaucoma	0.000684	0.00163	CcSEcCtD
Argatroban—Pain—Pilocarpine—glaucoma	0.000684	0.00163	CcSEcCtD
Argatroban—Cough—Clonidine—glaucoma	0.000683	0.00162	CcSEcCtD
Argatroban—F2—Folate Metabolism—MTHFR—glaucoma	0.000683	0.0109	CbGpPWpGaD
Argatroban—Dizziness—Apraclonidine—glaucoma	0.000683	0.00162	CcSEcCtD
Argatroban—F2—Syndecan-4-mediated signaling events—MMP9—glaucoma	0.000682	0.0109	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000677	0.0108	CbGpPWpGaD
Argatroban—F2—PAR1-mediated thrombin signaling events—NOS3—glaucoma	0.000671	0.0107	CbGpPWpGaD
Argatroban—Abdominal pain—Dorzolamide—glaucoma	0.000669	0.00159	CcSEcCtD
Argatroban—Body temperature increased—Dorzolamide—glaucoma	0.000669	0.00159	CcSEcCtD
Argatroban—Chest pain—Clonidine—glaucoma	0.000667	0.00158	CcSEcCtD
Argatroban—Abdominal pain—Travoprost—glaucoma	0.000667	0.00158	CcSEcCtD
Argatroban—Dizziness—Bimatoprost—glaucoma	0.000662	0.00157	CcSEcCtD
Argatroban—Feeling abnormal—Pilocarpine—glaucoma	0.000659	0.00157	CcSEcCtD
Argatroban—Vomiting—Apraclonidine—glaucoma	0.000657	0.00156	CcSEcCtD
Argatroban—Gastrointestinal pain—Pilocarpine—glaucoma	0.000654	0.00155	CcSEcCtD
Argatroban—Hypersensitivity—Brimonidine—glaucoma	0.000653	0.00155	CcSEcCtD
Argatroban—Bradycardia—Timolol—glaucoma	0.000651	0.00155	CcSEcCtD
Argatroban—Dermatitis—Apraclonidine—glaucoma	0.000651	0.00155	CcSEcCtD
Argatroban—Headache—Apraclonidine—glaucoma	0.000647	0.00154	CcSEcCtD
Argatroban—Confusional state—Clonidine—glaucoma	0.000644	0.00153	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.000635	0.0101	CbGpPWpGaD
Argatroban—Infection—Clonidine—glaucoma	0.000635	0.00151	CcSEcCtD
Argatroban—Abdominal pain—Pilocarpine—glaucoma	0.000633	0.0015	CcSEcCtD
Argatroban—Body temperature increased—Pilocarpine—glaucoma	0.000633	0.0015	CcSEcCtD
Argatroban—Diarrhoea—Acetazolamide—glaucoma	0.000632	0.0015	CcSEcCtD
Argatroban—Rash—Bimatoprost—glaucoma	0.000631	0.0015	CcSEcCtD
Argatroban—Dermatitis—Bimatoprost—glaucoma	0.000631	0.0015	CcSEcCtD
Argatroban—Headache—Bimatoprost—glaucoma	0.000627	0.00149	CcSEcCtD
Argatroban—Hypersensitivity—Dorzolamide—glaucoma	0.000624	0.00148	CcSEcCtD
Argatroban—Tachycardia—Clonidine—glaucoma	0.000624	0.00148	CcSEcCtD
Argatroban—Hypersensitivity—Travoprost—glaucoma	0.000621	0.00148	CcSEcCtD
Argatroban—Nausea—Apraclonidine—glaucoma	0.000614	0.00146	CcSEcCtD
Argatroban—Hypersensitivity—Brinzolamide—glaucoma	0.000613	0.00146	CcSEcCtD
Argatroban—Dizziness—Acetazolamide—glaucoma	0.000611	0.00145	CcSEcCtD
Argatroban—Hypotension—Clonidine—glaucoma	0.000597	0.00142	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.000595	0.0095	CbGpPWpGaD
Argatroban—Cough—Betaxolol—glaucoma	0.000595	0.00141	CcSEcCtD
Argatroban—Nausea—Bimatoprost—glaucoma	0.000595	0.00141	CcSEcCtD
Argatroban—Hypersensitivity—Pilocarpine—glaucoma	0.00059	0.0014	CcSEcCtD
Argatroban—Vomiting—Acetazolamide—glaucoma	0.000587	0.0014	CcSEcCtD
Argatroban—Dizziness—Brimonidine—glaucoma	0.000586	0.00139	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000586	0.00935	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—DHPS—glaucoma	0.000581	0.00928	CbGpPWpGaD
Argatroban—Angiopathy—Timolol—glaucoma	0.00058	0.00138	CcSEcCtD
Argatroban—Chest pain—Betaxolol—glaucoma	0.00058	0.00138	CcSEcCtD
Argatroban—Diarrhoea—Dorzolamide—glaucoma	0.000579	0.00138	CcSEcCtD
Argatroban—Headache—Acetazolamide—glaucoma	0.000579	0.00137	CcSEcCtD
Argatroban—Diarrhoea—Travoprost—glaucoma	0.000577	0.00137	CcSEcCtD
Argatroban—F2—GPCR ligand binding—OPN4—glaucoma	0.000573	0.00914	CbGpPWpGaD
Argatroban—Dyspnoea—Clonidine—glaucoma	0.00057	0.00135	CcSEcCtD
Argatroban—Diarrhoea—Brinzolamide—glaucoma	0.00057	0.00135	CcSEcCtD
Argatroban—Confusional state—Betaxolol—glaucoma	0.000561	0.00133	CcSEcCtD
Argatroban—Dizziness—Dorzolamide—glaucoma	0.00056	0.00133	CcSEcCtD
Argatroban—Rash—Brimonidine—glaucoma	0.000559	0.00133	CcSEcCtD
Argatroban—Dermatitis—Brimonidine—glaucoma	0.000559	0.00133	CcSEcCtD
Argatroban—Dizziness—Travoprost—glaucoma	0.000558	0.00132	CcSEcCtD
Argatroban—Headache—Brimonidine—glaucoma	0.000556	0.00132	CcSEcCtD
Argatroban—Infection—Betaxolol—glaucoma	0.000553	0.00131	CcSEcCtD
Argatroban—Gastrointestinal disorder—Clonidine—glaucoma	0.000552	0.00131	CcSEcCtD
Argatroban—Dizziness—Brinzolamide—glaucoma	0.000551	0.00131	CcSEcCtD
Argatroban—Nausea—Acetazolamide—glaucoma	0.000549	0.0013	CcSEcCtD
Argatroban—Diarrhoea—Pilocarpine—glaucoma	0.000548	0.0013	CcSEcCtD
Argatroban—Constipation—Clonidine—glaucoma	0.000546	0.0013	CcSEcCtD
Argatroban—Pain—Clonidine—glaucoma	0.000546	0.0013	CcSEcCtD
Argatroban—Tachycardia—Betaxolol—glaucoma	0.000543	0.00129	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000543	0.00866	CbGpPWpGaD
Argatroban—Vomiting—Dorzolamide—glaucoma	0.000538	0.00128	CcSEcCtD
Argatroban—Rash—Dorzolamide—glaucoma	0.000534	0.00127	CcSEcCtD
Argatroban—Dermatitis—Dorzolamide—glaucoma	0.000533	0.00127	CcSEcCtD
Argatroban—Rash—Travoprost—glaucoma	0.000532	0.00126	CcSEcCtD
Argatroban—Dermatitis—Travoprost—glaucoma	0.000531	0.00126	CcSEcCtD
Argatroban—Headache—Dorzolamide—glaucoma	0.000531	0.00126	CcSEcCtD
Argatroban—Vomiting—Brinzolamide—glaucoma	0.000529	0.00126	CcSEcCtD
Argatroban—Dizziness—Pilocarpine—glaucoma	0.000529	0.00126	CcSEcCtD
Argatroban—Headache—Travoprost—glaucoma	0.000528	0.00125	CcSEcCtD
Argatroban—Nausea—Brimonidine—glaucoma	0.000527	0.00125	CcSEcCtD
Argatroban—Feeling abnormal—Clonidine—glaucoma	0.000527	0.00125	CcSEcCtD
Argatroban—Rash—Brinzolamide—glaucoma	0.000525	0.00125	CcSEcCtD
Argatroban—Dermatitis—Brinzolamide—glaucoma	0.000524	0.00125	CcSEcCtD
Argatroban—Gastrointestinal pain—Clonidine—glaucoma	0.000523	0.00124	CcSEcCtD
Argatroban—Headache—Brinzolamide—glaucoma	0.000522	0.00124	CcSEcCtD
Argatroban—Hypotension—Betaxolol—glaucoma	0.00052	0.00123	CcSEcCtD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000518	0.00826	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PTGFR—glaucoma	0.000516	0.00823	CbGpPWpGaD
Argatroban—Vomiting—Pilocarpine—glaucoma	0.000509	0.00121	CcSEcCtD
Argatroban—Abdominal pain—Clonidine—glaucoma	0.000505	0.0012	CcSEcCtD
Argatroban—Body temperature increased—Clonidine—glaucoma	0.000505	0.0012	CcSEcCtD
Argatroban—Rash—Pilocarpine—glaucoma	0.000505	0.0012	CcSEcCtD
Argatroban—Dermatitis—Pilocarpine—glaucoma	0.000504	0.0012	CcSEcCtD
Argatroban—Nausea—Dorzolamide—glaucoma	0.000503	0.00119	CcSEcCtD
Argatroban—Headache—Pilocarpine—glaucoma	0.000501	0.00119	CcSEcCtD
Argatroban—Nausea—Travoprost—glaucoma	0.000501	0.00119	CcSEcCtD
Argatroban—Dyspnoea—Betaxolol—glaucoma	0.000496	0.00118	CcSEcCtD
Argatroban—Nausea—Brinzolamide—glaucoma	0.000495	0.00117	CcSEcCtD
Argatroban—Dyspepsia—Betaxolol—glaucoma	0.00049	0.00116	CcSEcCtD
Argatroban—Cough—Timolol—glaucoma	0.000486	0.00115	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000481	0.00767	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Betaxolol—glaucoma	0.00048	0.00114	CcSEcCtD
Argatroban—Pain—Betaxolol—glaucoma	0.000476	0.00113	CcSEcCtD
Argatroban—Constipation—Betaxolol—glaucoma	0.000476	0.00113	CcSEcCtD
Argatroban—Nausea—Pilocarpine—glaucoma	0.000475	0.00113	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—MMP1—glaucoma	0.000475	0.00758	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000475	0.00757	CbGpPWpGaD
Argatroban—Chest pain—Timolol—glaucoma	0.000474	0.00113	CcSEcCtD
Argatroban—Hypersensitivity—Clonidine—glaucoma	0.000471	0.00112	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000468	0.00747	CbGpPWpGaD
Argatroban—Feeling abnormal—Betaxolol—glaucoma	0.000458	0.00109	CcSEcCtD
Argatroban—Confusional state—Timolol—glaucoma	0.000458	0.00109	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—CAV1—glaucoma	0.000456	0.00727	CbGpPWpGaD
Argatroban—Infection—Timolol—glaucoma	0.000452	0.00107	CcSEcCtD
Argatroban—Body temperature increased—Betaxolol—glaucoma	0.00044	0.00104	CcSEcCtD
Argatroban—Diarrhoea—Clonidine—glaucoma	0.000437	0.00104	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—FN1—glaucoma	0.000434	0.00692	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000433	0.0069	CbGpPWpGaD
Argatroban—Hypotension—Timolol—glaucoma	0.000425	0.00101	CcSEcCtD
Argatroban—Dizziness—Clonidine—glaucoma	0.000423	0.001	CcSEcCtD
Argatroban—Hypersensitivity—Betaxolol—glaucoma	0.00041	0.000974	CcSEcCtD
Argatroban—Vomiting—Clonidine—glaucoma	0.000406	0.000965	CcSEcCtD
Argatroban—Dyspnoea—Timolol—glaucoma	0.000405	0.000962	CcSEcCtD
Argatroban—Rash—Clonidine—glaucoma	0.000403	0.000957	CcSEcCtD
Argatroban—Dermatitis—Clonidine—glaucoma	0.000403	0.000956	CcSEcCtD
Argatroban—Headache—Clonidine—glaucoma	0.0004	0.000951	CcSEcCtD
Argatroban—Dyspepsia—Timolol—glaucoma	0.0004	0.00095	CcSEcCtD
Argatroban—Gastrointestinal disorder—Timolol—glaucoma	0.000392	0.000932	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00039	0.00622	CbGpPWpGaD
Argatroban—Pain—Timolol—glaucoma	0.000389	0.000923	CcSEcCtD
Argatroban—Diarrhoea—Betaxolol—glaucoma	0.000381	0.000904	CcSEcCtD
Argatroban—Nausea—Clonidine—glaucoma	0.00038	0.000902	CcSEcCtD
Argatroban—Feeling abnormal—Timolol—glaucoma	0.000375	0.00089	CcSEcCtD
Argatroban—Gastrointestinal pain—Timolol—glaucoma	0.000372	0.000883	CcSEcCtD
Argatroban—Dizziness—Betaxolol—glaucoma	0.000368	0.000874	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.000367	0.00586	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTSA—glaucoma	0.000363	0.00579	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—TNF—glaucoma	0.000362	0.00577	CbGpPWpGaD
Argatroban—Body temperature increased—Timolol—glaucoma	0.000359	0.000853	CcSEcCtD
Argatroban—Abdominal pain—Timolol—glaucoma	0.000359	0.000853	CcSEcCtD
Argatroban—Vomiting—Betaxolol—glaucoma	0.000354	0.00084	CcSEcCtD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000352	0.00562	CbGpPWpGaD
Argatroban—Rash—Betaxolol—glaucoma	0.000351	0.000833	CcSEcCtD
Argatroban—Dermatitis—Betaxolol—glaucoma	0.00035	0.000832	CcSEcCtD
Argatroban—Headache—Betaxolol—glaucoma	0.000349	0.000828	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—PTGS2—glaucoma	0.000346	0.00553	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—EDN1—glaucoma	0.00034	0.00543	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—EDN1—glaucoma	0.000336	0.00536	CbGpPWpGaD
Argatroban—Hypersensitivity—Timolol—glaucoma	0.000335	0.000795	CcSEcCtD
Argatroban—F2—Metabolism of proteins—ACE2—glaucoma	0.000334	0.00533	CbGpPWpGaD
Argatroban—Nausea—Betaxolol—glaucoma	0.00033	0.000785	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000328	0.00523	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—OPN4—glaucoma	0.000324	0.00517	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—FN1—glaucoma	0.000313	0.00499	CbGpPWpGaD
Argatroban—Diarrhoea—Timolol—glaucoma	0.000311	0.000739	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000304	0.00485	CbGpPWpGaD
Argatroban—Dizziness—Timolol—glaucoma	0.000301	0.000714	CcSEcCtD
Argatroban—F2—Folate Metabolism—TNF—glaucoma	0.000294	0.0047	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—OPN4—glaucoma	0.000294	0.00469	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—C3—glaucoma	0.000293	0.00468	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PTGFR—glaucoma	0.000291	0.00465	CbGpPWpGaD
Argatroban—Vomiting—Timolol—glaucoma	0.000289	0.000686	CcSEcCtD
Argatroban—Rash—Timolol—glaucoma	0.000287	0.000681	CcSEcCtD
Argatroban—Dermatitis—Timolol—glaucoma	0.000286	0.00068	CcSEcCtD
Argatroban—Headache—Timolol—glaucoma	0.000285	0.000676	CcSEcCtD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000276	0.00441	CbGpPWpGaD
Argatroban—Nausea—Timolol—glaucoma	0.00027	0.000641	CcSEcCtD
Argatroban—F2—Signaling by GPCR—PTGFR—glaucoma	0.000265	0.00422	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—SMO—glaucoma	0.00026	0.00415	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.00026	0.00415	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—glaucoma	0.000259	0.00414	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LRP12—glaucoma	0.000251	0.004	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—glaucoma	0.000234	0.00373	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000228	0.00364	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000225	0.00359	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000224	0.00357	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB2—glaucoma	0.000223	0.00356	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000221	0.00352	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000207	0.0033	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000204	0.00326	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000197	0.00314	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NARFL—glaucoma	0.000182	0.00291	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA5A—glaucoma	0.000182	0.00291	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000181	0.00289	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—PAX6—glaucoma	0.000178	0.00284	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—OPN4—glaucoma	0.000174	0.00277	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—EDN1—glaucoma	0.000171	0.00274	CbGpPWpGaD
Argatroban—F2—Hemostasis—SOD1—glaucoma	0.000169	0.0027	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—glaucoma	0.000166	0.00264	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	0.000163	0.00261	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HEYL—glaucoma	0.000161	0.00258	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTGFR—glaucoma	0.000156	0.0025	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—C3—glaucoma	0.00015	0.00239	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SMO—glaucoma	0.000133	0.00213	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000131	0.00208	CbGpPWpGaD
Argatroban—F2—Hemostasis—MMP1—glaucoma	0.000129	0.00206	CbGpPWpGaD
Argatroban—F2—Hemostasis—CAV1—glaucoma	0.000124	0.00197	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RPTOR—glaucoma	0.000122	0.00195	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000121	0.00193	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NCK2—glaucoma	0.000118	0.00189	CbGpPWpGaD
Argatroban—F2—Hemostasis—FN1—glaucoma	0.000118	0.00188	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP1—glaucoma	0.000101	0.00162	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HDAC9—glaucoma	0.000101	0.00161	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—EDN1—glaucoma	9.69e-05	0.00155	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.63e-05	0.00154	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.49e-05	0.00152	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS3—glaucoma	9.34e-05	0.00149	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA1—glaucoma	8.89e-05	0.00142	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDN1—glaucoma	8.8e-05	0.0014	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CTSA—glaucoma	8.61e-05	0.00137	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA5A—glaucoma	8.47e-05	0.00135	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NARFL—glaucoma	8.47e-05	0.00135	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—C3—glaucoma	8.46e-05	0.00135	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CA2—glaucoma	8.14e-05	0.0013	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SMO—glaucoma	7.88e-05	0.00126	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—glaucoma	7.84e-05	0.00125	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.7e-05	0.00123	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—C3—glaucoma	7.69e-05	0.00123	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.59e-05	0.00121	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NTRK2—glaucoma	7.21e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—glaucoma	6.73e-05	0.00107	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NGFR—glaucoma	6.19e-05	0.000987	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NTRK1—glaucoma	5.88e-05	0.000938	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TXN—glaucoma	5.73e-05	0.000915	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN2B—glaucoma	5.42e-05	0.000864	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—glaucoma	5.2e-05	0.000829	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—glaucoma	5.09e-05	0.000812	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NGF—glaucoma	4.78e-05	0.000762	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—C3—glaucoma	4.54e-05	0.000725	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—glaucoma	4.44e-05	0.000709	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—glaucoma	4.23e-05	0.000675	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CAV1—glaucoma	4.19e-05	0.000668	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA1—glaucoma	4.14e-05	0.00066	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CTSA—glaucoma	4.01e-05	0.000639	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FN1—glaucoma	3.99e-05	0.000636	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BAD—glaucoma	3.94e-05	0.000629	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CA2—glaucoma	3.78e-05	0.000604	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCA1—glaucoma	3.54e-05	0.000565	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1B1—glaucoma	3.54e-05	0.000565	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOS3—glaucoma	3.17e-05	0.000505	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—glaucoma	2.83e-05	0.000452	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN1B—glaucoma	2.74e-05	0.000438	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TXN—glaucoma	2.66e-05	0.000425	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—glaucoma	2.54e-05	0.000405	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—glaucoma	2.5e-05	0.000399	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—glaucoma	2.33e-05	0.000372	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAV1—glaucoma	2.31e-05	0.000368	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—glaucoma	2.28e-05	0.000364	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—glaucoma	2.07e-05	0.00033	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NOS3—glaucoma	1.74e-05	0.000278	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—glaucoma	1.72e-05	0.000275	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1B1—glaucoma	1.65e-05	0.000263	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCA1—glaucoma	1.65e-05	0.000263	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—glaucoma	1.6e-05	0.000255	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—glaucoma	1.32e-05	0.00021	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—glaucoma	1.16e-05	0.000186	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—glaucoma	1.08e-05	0.000173	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAV1—glaucoma	1.07e-05	0.000171	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NOS3—glaucoma	8.11e-06	0.000129	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—glaucoma	7.42e-06	0.000118	CbGpPWpGaD
